Neonatal Acute Renal Failure in Preterm Clinical Trial
— IRENEOOfficial title:
Renal Prognosis of Former Preterm Infants 3 to 10 Years After Neonatal Acute Renal Failure
| Verified date | October 2014 |
| Source | Nantes University Hospital |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | France:ANSM |
| Study type | Interventional |
The aim of this study is to evaluate the signs of nephronic reduction in preterm infants who have presented neonatal acute renal failure. The investigators hypothesize that signs of nephronic reduction would appear earlier in former preterm with neonatal acute renal failure than in control preterm infants.
| Status | Completed |
| Enrollment | 75 |
| Est. completion date | October 2013 |
| Est. primary completion date | October 2013 |
| Accepts healthy volunteers | Accepts Healthy Volunteers |
| Gender | Both |
| Age group | 3 Years to 10 Years |
| Eligibility |
Inclusion Criteria: - For both group of cases (50 infants having presented acute renal failure in preterm) AND group of control cases (25 infants without this) :former preterm infant born before 33 weeks of gestational age between january 2003 and june 2010 and hospitalized in the neonatal intensive care unit of Nantes University Hospital. - Specific to cases: neonatal acute renal failure: serum creatinine>130 micromol/l from the third day of life. - Control cases: no such renal dysfunction Exclusion Criteria: - no parental consent - other causes of renal failure: congenital uropathy, congenital nephropathy - congenital cardiopathy, polymalformative syndrome |
Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Health Services Research
| Country | Name | City | State |
|---|---|---|---|
| France | CHU of Nantes | Nantes |
| Lead Sponsor | Collaborator |
|---|---|
| Nantes University Hospital |
France,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | microalbuminuria | The primary outcome of this study is to prove that former preterm infants with neonatal acute renal failure are at higher risk of nephronic reduction than control former preterm infants and that they will present microalbuminuria as earlier sign of nephronic reduction. Precisely, if microalbuminuria divided by creatinuria is above 20mg/g or 2mg/mmol, it will be considered as pathologic. | Day 1 (at inclusion) | No |
| Secondary | measurement of blood pressure | Evaluation of other renal parameters: blood pressure, renal filtration, tubular functions evaluation of renal size and differentiation by ultrasound | Day 1 (at inclusion) | No |
| Secondary | measurement of length and volume of kidney by renal echography | day 1 | No | |
| Secondary | creatinine clearance | day 1 | No | |
| Secondary | calciuria | Day 1 | No | |
| Secondary | sodium clearance | day 1 | No |